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Abstract
Background: Inappropriate cross talk between mammals and their gut microbiota may trigger intestinal inflammation and
drive extra-intestinal immune-mediated diseases. Epithelial cells constitute the interface between gut microbiota and host
tissue, and may regulate host responses to commensal enteric bacteria. Gnotobiotic animals represent a powerful approach
to study bacterial-host interaction but are not readily accessible to the wide scientific community. We aimed at refining a
protocol that in a robust manner would deplete the cultivable intestinal microbiota of conventionally raised mice and that
would prove to have significant biologic validity.
Methodology/Principal Findings: Previously published protocols for depleting mice of their intestinal microbiota by
administering broad-spectrum antibiotics in drinking water were difficult to reproduce. We show that twice daily delivery of
antibiotics by gavage depleted mice of their cultivable fecal microbiota and reduced the fecal bacterial DNA load by 400
fold while ensuring the animals’ health. Mice subjected to the protocol for 17 days displayed enlarged ceca, reduced Peyer’s
patches and small spleens. Antibiotic treatment significantly reduced the expression of antimicrobial factors to a level
similar to that of germ-free mice and altered the expression of 517 genes in total in the colonic epithelium. Genes involved
in cell cycle were significantly altered concomitant with reduced epithelial proliferative activity in situ assessed by Ki-67
expression, suggesting that commensal microbiota drives cellular proliferation in colonic epithelium.
Conclusion: We present a robust protocol for depleting conventionally raised mice of their cultivatable intestinal microbiota
with antibiotics by gavage and show that the biological effect of this depletion phenocopies physiological characteristics of
germ-free mice.
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Introduction
The human gut harbors a microbiological community of 10
14
bacteria consisting of more than a 1000 species whose collective
genome (‘‘microbiome’’) outnumbers the human genome by more
than a 100 fold[1,2]. The cross talk between the host and its
intestinal microbiota is of obvious significancefor the function of the
intestines[3], and has also been shown to be important for immune-
mediated diseases with extra-intestinal manifestations such as in
allergy and asthma[4]. More recently the influence of the intestinal
microbiota in experimental models for both type 1 diabetes,
obesity, and multiple sclerosis has been demonstrated[5–7].
Microbe-associated molecular patterns (MAMPs) use an array of
germ-line encoded pattern recognition receptors (PRRs) to
activate signaling pathways in host cells [8,9]. Importantly,
signaling via these receptors drive host inflammatory responses to
microbes[10–12], but can also mediate mucosal homeostasis and
integrity when the microbe or microbial product is delivered via
the intestinal lumen to the intact epithelium[8,9]. Functional
assessments of the intestinal microbiota’s impact on the host is
thus of great interest.
The intestinal epithelium, consisting of a single cell layer,
composes the barrier between the host sterile environment and the
bacteria-rich intestinal lumen. Having only a partially bacteria-
free mucus layer as a mechanical shield[13], the intestinal
epithelial cells (IECs) are in direct contact with the highly diverse
microbiota[14,15]. The enterocytes express a wide range of PRRs
whose functions and engagement by MAMPs are essential for the
homeostasis of the intestinal mucosa[8,9]. The other way around,
IECs are shown to modulate the microbiota through the secretion
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facilitating the transport of secretory IgA[17,18]. Even though the
close and mutual relationship between the intestinal microbiota
and the IECs is demonstrated, very little knowledge exists about
how the full gene expression repertoire in the colonic IECs is
regulated by the presence of a complete conventional microbiota.
Germ-free animals bred in sterile environment may potentially
be used for such comparative studies. However, establishing and
running germ-free facilities is expensive and requires special
expertise and infra-structure. Compared with animals living in a
conventional microbiological environment, germ-free animals
display an immature and underdeveloped lymphoid system[19].
A generally accessible alternative to using germ-free animals for
studying host-microbe interaction in vivo is to deplete animals of
their intestinal microbiota by using a combination of broad
spectrum antibiotics administered per os. In a hallmark paper,
Rakoff-Nahoum and colleagues delivered broad-spectrum antibi-
otics in the drinking water to demonstrate that intestinal MAMPs
signaling via Toll-like receptors (TLRs) supported gut homeosta-
sis[20]. However, many have found it difficult to reproduce this
protocol, and researchers who have succeeded in making mice
drink the antibiotics ad libitum have experienced increased baseline
morbidity and mortality among some strains and genotypes of
mice subjected to this protocol (W. Garrett, personal communi-
cation). Importantly, several published papers that report to have
applied this intestinal microbiota depletion protocol describe
incomplete depletion of the cultivable bacteria[21–23].
In order to compare the gene expression profiles of colonic IECs
in the presence and absence of a complete intestinal microbiota,
we determined to refine a protocol that would deplete mice of their
cultivable intestinal microbiota in a predictable and reproducible
manner while ensuring the health of the animals. We demonstrate
that applying this refined protocol we obtain mice which resemble
germ-free mice in terms of hypoplastic lymphoid tissue. Impor-
tantly, antibiotic-gavaged mice have significantly altered gene
expression profiles of colonic IECs resembling those of germ-free
mice and affecting a wide range of pathways.
Results
Delivering antibiotics by gavage ensures health of the
mice
We attempted to deplete mice of their intestinal microbiota by
providing ampicillin, vancomycin, neomycin, and metronidazol ad
libitum in drinking water according to the previously published
protocol[20]. However, BALB/c mice consistently refrained from
drinking the concoction, presumably due to the foul taste of
metronidazol (Figure 1A). Respecting the ethical standards of our
animal facility and the humane end point of .20% loss of baseline
body weight, we had to euthanize all mice receiving the full
antibiotic combination (Figure 1B). Adding low caloric aspartame-
based sweetener with the concoction in an attempt to mask the
taste of the antibiotics also failed (Figure 1C, D). C57BL/6 mice
displayed the same unwillingness as BALB/c mice to drink the
antibiotic concoction provided ad libitum (data not shown).
To ensure a safe and stable delivery of the antibiotic concoction
to every mouse subjected to the protocol we administered it by
gavage every 12 hours. Due to occasional overgrowth of Candida
spp. in pilot experiments (data not shown), we initiated our
protocol with 3 days treatment of gavaging the antifungal
substance amphotericin-B (1 mg/kg bodyweight (BW)) attempting
to suppress fungal growth prior to starting the antibacterial
treatment (Figure 2A). From day 3, ampicillin 1 mg/ml was added
to drinking water and mice were gavaged every 12 hours with the
antibiotic concoction consisting of vancomycin 50 mg/kg BW,
neomycin 100 mg/kg BW, metronidazol 100 mg/kg BW, and
amphotericin-B 1 mg/kg BW.
Gavaging mice did not inflict detectable distress or pain. Six
weeks old mice given water gavage of a volume and frequency
identical to the mice receiving the antibiotic concoction displayed
unaltered weight gain compared with mice receiving water ad
libitum only (Figure 2B). Some mice gavaged with antibiotic
concoction experienced a transient weight loss on day 4–5 after
introduction of the antibacterial therapy (Figure 2B). This
transient weight loss we believe was caused by mice adjusting to
ampicillin in drinking water rather than the gavaged concoction as
we observed that mice receiving ampicillin in drinking water as
only therapy had the same transient drop in body weight
(Figure 1B). Within a week mice receiving the full antibiotic
therapy had regained their weight compared with their untreated
peers and appeared healthy.
Antibiotic therapy by gavage effectively depletes
cultivable microbiota and reduces fecal bacterial DNA
load
Fecal bacteria of untreated mice were enumerated by
cultivations of serial dilutions of resuspended fecal pellets on
differential media (Figure 3A). Validation of successful depletion
after the antibiotic gavage treatment was performed by cultivation
of fecal pellets collected and handled aseptically on day 13 and 24.
Due to limitations in the quantity of fresh fecal pellets that could
be collected, the detection limit for this assay was set to 1 cfu/mg
feces and mice with , 1cfu/mg feces were defined as successfully
depleted. Only animals successfully depleted by this criterion were
included in further characterization of antibiotic treated mice. At
day 13, 86% of the mice subjected to the protocol displayed
successful depletion of their cultivable aerobic and anaerobic fecal
microbiota (Figure 3B). At day 24, the corresponding fraction was
74%. Thus, in depleted mice (,1 cfu/mg feces), we obtained a
minimum of 100-fold reduction of cultivable aerobic Gram
negative rods and 10
6-fold reduction of cultivable aerobic Gram
positive cocci as well as cultivable anaerobic fecal bacteria. A
similar depletion efficacy was obtained in C57BL/6 mice as in
BALB/c mice (data not shown).
As the majority of the intestinal microbiota is not cultivable[1]
we estimated the load of bacterial DNA in feces by 16S rRNA
gene quantitative polymerase chain reaction (qPCR). DNA from
fecal pellets was isolated and the V2 and the V6 region of bacterial
16S rRNA genes amplified with degenerate primers targeted to
conserved flanking sequences. Due to shedding of epithelial cells,
feces contain host DNA. Taking advantage of this we quantified
mouse DNA by qPCR and used this value to normalize the
amount of bacterial 16S DNA present (Figure 3C). We found that
all mice subjected to the depletion protocol had significantly
reduced copy number of 16S rRNA genes in their feces: the level
of bacterial DNA was similar in all samples of antibiotic treated
mice and, on average, more than 400 fold less than the level in
untreated mice demonstrating the effect of the microbiota
depletion protocol.
Depletion of gut microbiota produces a macroscopically
germ free-like phenotype
Mice born and raised in a germ-free environment possess
numerous characteristics distinguishing them from mice living
in a conventional microbiological environment. Macroscopi-
cally, germ-free mice display hypoplastic secondary lymphoid
organs, enlarged ceca, and reduced epithelial cell turnover[19].
Depleted Intestinal Microbiota in Mice
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the antibiotic concoction by gavage for 17 days displayed
significantly fewer Peyer’s patches, smaller spleens and enlarged
ceca (Figure 4A–D), macroscopically phenocopying germ-free
mice.
Immuno luorescent staining of sections from the colon of these
same animals demonstrated that they had acquired a reduced
epithelial regenerative activity in terms of fewer Ki67
+ cells than
what was observed in mice with an intact intestinal microbiota
(Figure 4E, F).
Depletion of gut microbiota alters gene expression in
colonic epithelium illustrative of germ-free mice
As we observed that the refined depletion protocol affected
such a basic function of IECs as the regenerative activity, we
wanted to study how the intestinal microbiota affected IECs
globally by performing gene expression profile analysis on
isolated colonic IECs of mice successfully depleted by the refined
microbiota depletion protocol compared with that of sham
treated control mice. We identified a total of 517 differentially
expressed genes. However, many of these genes only showed a
small alteration in expression level between antibiotic treated and
control animals.
Focusing on genes with at least a 2-fold altered expression 36
genes were higher expressed and 70 genes showed reduced
expression upon antibiotic treatment (Figure 5A). Gene ontology
analysis revealed that expression of genes related to cell cycle and
lipid biosynthesis were the most affected of the antibiotic treatment
but also inflammatory response genes were significantly altered
(Figure 5B). Strikingly, 5 of the 7 genes that had more than 4-fold
reduced expression in antibiotic treated mice encode known
antimicrobial factors[24–29] (Table 1).
To validate the gene expression profile and its relevance to
germ-free mice we performed quantitative reverse transcriptase
(qRT)-PCR on all nine genes that showed more than 4-fold
differential expression by microarray analysis (Table 1). For all
nine genes tested, the qRT-PCR confirmed the differential
expression between antibiotic-gavged and sham-treated mice
discovered in the array (Figure 6). In all cases, the fold difference
between the two groups was greater when gene expression was
determined by qRT-PCR than by micro array. Moreover,
differential gene expression of colonic IEC from germ-free mice
versus conventional age- and gender matched controls showed
similar pattern as the antibiotic-gavaged versus sham treated mice.
For most of the genes the antibiotic treated and germ-free mice
showed similar expression levels (Figure 6).
Figure 1. Mice refrain from drinking antibiotics ad libitum. Experiments attempting to administer mice ampicillin 1 g/l (A), vancomycin
500 mg/ml (V), neomycin 1 g/l (N), and metronidazol 1 g/l (M) in drinking water ad libitum. Water indicates mice receiving regular drinking water.
Skulls represent euthanized animals. Stapled lines indicate humane endpoint of 20% loss of body weight. Treatment groups presented as mean 6
SD. Deceased mice excluded from subsequent time points after death. (A) Daily fluid consumption estimated by daily weighting of flasks and (B)
bodyweight presented as percent of baseline (= Day 0) for mice receiving the full AVNM concoction (red) in drinking water as well as for mice
receiving the individual antibiotics as single solutions in drinking water, n=5 for all groups. (C) Daily fluid consumption and (D) bodyweight
presented as percent of baseline (=Day 0) attempting to mask the foul taste of the antibiotic concoction AVNM in drinking water by adding the
aspartame-based sweetener CanderelH 1.5% weight/volume, n=6 for AVNM + CanderelH 1.5% group, n=4 for water control group.
doi:10.1371/journal.pone.0017996.g001
Depleted Intestinal Microbiota in Mice
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17996Discussion
Recently, there has been an increased understanding of the
importance of intestinal microbiota for human physiology,
evidenced by large endeavors such as the MetaHIT project[2]
and the Human Microbiome Project[30]. However, simple
protocols for manipulation of intestinal microbiota in experimental
animals are also needed. Thus, the seemingly simple method of
depleting mice of their cultivatable microbiota by adding a
concoction of antibiotics in drinking water has gained a lot of
Figure 2. Protocol for administering antibiotics by gavage ensures mice health. (A) Sketch of protocol for gavage administration of
vancomycin 50 mg/kg (V), neomycin 100 mg/kg (N), metronidazol 100 mg/kg (M), and amphotericin-B 1 mg/kg (Amf-B) every 12 hours with
ampicillin 1 g/l ad libitum in drinking water (A). (B) Body weight, presented as percent of base line (=Day 0), of mice successfully depleted of
cultivable fecal microbiota by gavage (VNMAmf-B+A) or gavaged with water in equivalent volume and frequency (Sham). Control mice received
water ad libitum only
doi:10.1371/journal.pone.0017996.g002
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gists. Although some labs have successfully used the ad libitum
protocol to obtain valuable data, it appears that it is not applicable
to all mouse strains or genotypes and that it is affected by the
general conditions in the vivarium. Here we have presented and
validated an alternative method which deliver the antibiotics in a
safe and predictable manner without inflicting any morbidity on
the animals. Furthermore, we demonstrated that mice subjected to
this depletion protocol acquire a germ free-like phenotype.
Our protocol for depletion of intestinal microbiota is based on
the same composition of antibacterial agents as others have
applied for ad libitum administration in drinking water. Ampicillin,
vancomycin, neomycin and metronidazol offer in combination
bactericidal activity against the full spectrum of bacteria and,
notably, dual activity against both Gram positive (ampicillin and
vancomycin) and Gram negative (ampicillin and neomycin)
aerobic and facultative strains, which is potentially important for
preventing antibiotic resistance [31]. We therefore used this
combination of antibiotics and overcame the delivery problems by
administering the antibiotics by gavage twice daily which the mice
tolerated well.
In mice treated with the gavage protocol for 17 days we
observed a reduction in the bacterial DNA load that was
substantial though numerically not as great as the reduction
observed in cultivation assays. This may reflect that the 16S DNA
qPCR detect DNA from dead as well as viable bacteria. Also, a
recent report demonstrated that bacterial DNA in the animal
chow contributes to the 16S DNA load in fecal pellets[32].
However, the fact that the few fecal samples in our assays that
contained cultivable bacteria did not distinguish themselves in
terms of higher 16S DNA load than the successfully depleted mice
(not shown) indicates that the qPCR assay is a more crude analysis.
Fecal pellets were used for evaluating the efficacy of the
microbiota depletion protocol. Microbes that preferentially adhere
to the mucosa of the mice are also affected by antibiotics[32] but
would not be thoroughly assessed by analysis of fecal pellets. Even
though the fecal pellets were devoid of cultivable bacteria and had
greatly reduced amount of bacterial DNA we acknowledge that
the intestines of the mice likely harbor residual bacteria and should
not be regarded as sterile, as in true germ-free mice. However,
collecting fecal pellets is non-invasive and allows for longitudinal
studies. Contrary to this, collecting intestinal tissue from mice to
confirm depletion of adherent bacteria would not be compatible
with having the same mice entering functional experiments.
Applying the gavage antibiotic depletion protocol had a profound
effect on the phenotype of the mice as they developed several
characteristics typical of germ-free mice. The reduced spleen,
number of Peyer’s patches, the enlarged ceca, and reduced
epithelial proliferative activity in our treated mice is also observed
in germ-free mice[19]. This suggests that these features are typical
of under-stimulation by commensals and that they are reversible
effects rather than a consequence of growing up germ free.
Furthermore, both mucosal and systemic secondary lymphoid
organs were affected by commensal depletion.
We assessed the impact of the intestinal microbiota on the
colonic IEC’s gene expression profile, which revealed that more
than 500 genes were differentially expressed as a consequence of
the antibiotic by gavage treatment. A number of genes related to
cell cycle were differentially regulated between untreated and
antibiotic treated mice, suggesting that the commensal microbiota
regulate epithelial proliferation in the colon. Furthermore,
pathways regulating lipid biosynthesis, specifically production of
arachidonic acid, appeared to be affected by the commensal
microbiota. This was due to reduced expression of several small
secreted phospholipases from the phospholipase A2 family after
antibiotic treatment. Recent reports suggest that these secreted
phosphoslipases are not primarily involved in arachidonic acid
production. Although they have enzymatic activity, they show no
substrate specificity for arachidonic acid release[26,33]. Further-
more, secreted phospholipases have been shown to have
antimicrobial activity[26,34].
In colonic IEC from germ free mice and matched conventional
mice we determined the expression level of nine genes strongly
affected by our antibiotics by gavage treatment. In eight out of
nine cases, differences between antibiotic and sham treated mice
were nearly identical to differences between germ-free and
conventional mice strongly suggesting that the altered gene
expression profile is a consequence of the highly reduced microbial
stimulation of the colonic IECs. For these eight genes we rule out
that altered gene expression due to antibiotic treatment was a
consequence of a direct pharmacologic effect of the antibiotics.
These comparisons support the validity of the antibiotic treatment
as an analogue to germ-free status in mice.
The greatest fold change was seen in genes coding for
antimicrobial factors, some of which (Ang4[24], Retnlb[25]
Reg3g[28] and Reg3b[25]) have been demonstrated to be induced
by microbial stimuli through mono-associating or conventionaliz-
ing germ-free mice or by comparing germ-free and conventionally
bred mice. Retnlb, Reg3g, and Reg3b have also previously been
shown to be down-regulated after antibiotic treatment[25,35].
These studies have been performed on samples from the small
intestines and we now complement these by demonstrating the
identical effect in the colon. We believe we are also the first to
demonstrate that in the colon high expression of the antimicrobial
factor Pla2g2a is dependent on the presence of the intestinal
microbiota, which is incongruent to previous observations in the
small intestines[24]. The reduced expression of antimicrobial
factors in IEC from mice depleted of commensal microbiota (to
levels similar to that of germ free mice) demonstrate that
continuous presence of microbial stimuli is required to maintain
normal expression level of these genes.
To our knowledge only one study has performed gene
expression profile comparison on colonic IECs from germ-free
and conventionally bread mice. In the infancy of array-based gene
expression assays Fukushima et al. compared mRNA expression
profiles of colonic IEC from germ-free mice with mice with
conventional non-pathogenic microbiota and confirmed two genes
downregulated and five genes upregulated in germ-free mice[36].
Of these seven genes four were similarly differentially expressed in
our microbiota depleted mice. This comparison lends further
support to our hypothesis that the differentially expressed genes in
Figure 3. Protocol for administering antibiotics by gavage effectively reduces intestinal bacterial contents. (A) Enumeration of
cultivable fecal bacteria (mean 6 SEM) in untreated mice. (B) Efficacy of successful depletion (,1 cfu/mg feces) of cultivable gut microbiota and
distribution of aerobe, anaerobe, and fungal overgrowth (def.: $1 cfu/mg feces) after 13 and 24 days of treatment with vancomycinm (V), neomycin
(N), metronidazol (M), and amphotericin-B (Amf-B) every 12 hours by gavage with ampicillin ad libitum in drinking water (A), n=43. (C) Bacterial 16S
DNA load (mean 6 SD) in fecal pellets. 16S DNA determined by quantitative PCR for the V2 and V6 regions and normalized to total mouse genomic
DNA in the same pellets of mice treated 13 and 24 days with VNMAmf-B +A compared with water controls, n=7 for water controls, 40 for 13 days,
and 35 for 24 days.
doi:10.1371/journal.pone.0017996.g003
Depleted Intestinal Microbiota in Mice
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17996Depleted Intestinal Microbiota in Mice
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17996our antibiotic treated mice are caused by greatly reduced
microbial stimuli.
Two recent publications reported to having gavaged mice
with ampicillin, vancomycin, neomycin and metronidazol[7,32].
In line with our experiments, Hill et al.d e m o n s t r a t e dt h ep i t f a l l
of the previously reported antibiotics ad libitum protocol and
showed that gavaging mice with antibiotics once daily gave a
significant reduction in bacterial 16S DNA load and altered gut
phenotype[32]. Ochoa-Reparaz et al. demonstrated that mice
gavaged with the antibiotics tolerated that treatment better than
the ad libitum approach[7]. Our protocol applied a gavage
frequency of twice daily and we used higher antibiotic
concentrations than Hill et al. and Ochoa-Reparaz et al. Thus,
we were able to reduce the fecal 16S DNA load by 400 fold
while Hill et al. reported a 10-fold reduction. We have
furthermore validated the gavage protocol demonstrating
acquisition of a ‘‘germ free-like’’ phenotype of the subjected
mice. We believe that our assessments of the macroscopic
appearance of lymphoid organs and colonic IEC gene
expression profile provide additional knowledge on how the
intestinal microbiota affects a mammalian organism.
In conclusion, we present a generally accessible protocol for
depleting mice of their cultivable intestinal microbiota by
administering an antibiotic concoction by gavage every 12 hours.
Our protocol showed increased feasibility compared with previous
protocols, provided a predictable delivery of the antibiotics and at
the same time ensuring the health of the animals. We have verified
the depletion efficacy of our protocol both in terms of cultivable
microbes and in terms of bacterial DNA load in feces. Finally, our
protocol proved to produce a germ free-like phenotype of the
animals subjected to the protocol, suggesting it to be a valid and
accessible way to perform experiments on the host-bacteria cross
talk in mice.
Materials and Methods
Ethics statement
All use of laboratory animals was approved by the National
Animal Research Authority (Forsøksdyrutvalget) (approval IDs:
48/05, 1468, and 1734) and conducted in accordance with the
Norwegian Animal Welfare Act and the Norwegian Regulation on
Animal Experimentation. Humane endpoint was set to loss of
.20% body weight compared with the starting weight in each
experiment.
Mice
BALB/c mice were bred and kept in a conventional laboratory
animal facility at Centre for Comparative Medicine, University of
Oslo with temperatures maintained at 21
oC and with 55% relative
humidity, 12 hour light and darkness cycles with 1 hour of dusk
and dawn. The mice received regular chow No. 3 (801080,
Special Diets Services, Witham, England) and water purified by
reverse osmosis and ionic exchange. Males 6–10 weeks of age were
used in experiments, age and weight matched for each individual
experiment to have an age span of maximum 2 weeks and a weight
range of maximum 620% of medians.
For reference controls in quantitative gene expression analyses 6
month old female BALB/c were obtained from the Clean Mouse
Facility (CMF),Department of Clinical Research, University of Bern.
Germ-free mice were bred and maintained in flexible film isolators
and germ-free status was routinely confirmed by aerobic and
anaerobic culture as well as DNA (sytox green; Invitrogen) and gram
staining (Harleco) of cecal contents to detect unculturable contam-
ination. Germ-free BALB/c mice were sacrificed under sterile
conditions and tissue collection was performed at the University of
Bern. Age- and gender matched conventionally kept controls were
from Centre for Comparative Medicine, University of Oslo.
Figure 4. Mice subjected to antibiotic gavage treatment alters macroscopic phenotype and epithelial proliferative activity. Numbers
of macroscopically visible Peyer’s patches (A), spleen weight (B), and cecal longitudinal cross section area (C), after 17 days of treatment with
vancomycin (V), neomycin (N), metronidazol (M), and amphotericin-B (Amf-B) every 12 hours by gavage with ampicillin ad libitum in drinking water
(A) compared to mice gavaged with water only (Sham). All VNMAmf-B+A treated mice exhibited successful depletion of cultivable intestinal
microbiota (,1 cfu/mg feces). (D) Photograph of VNMAmf-B+A and sham fed mice. Note the enlarged cecum (arrow) of the antibiotic treated mouse.
(E) Immunofluorescent staining for Ki67 (green) and DNA (Hoechst dye; blue) of cross sections of colons from VNMAmf-B+A fed mice and sham fed
mice with (F) enumeration of Ki67
+ cells per crypt. In all graphs each symbol represents one animal and horizontal bars represent medians. Statistical
differences calculated by Mann-Whitney two-tailed test.
doi:10.1371/journal.pone.0017996.g004
Table 1. Genes $ 4-fold differentially expressed in colonic epithelium of untreated conventional and antibiotic treated mice.
Gene symbol Product Function[Reference] Conventional/Antibiotic treated
Ang4 Angiogenin, ribonuclease A family, member 4 AMF[24] 17.8
Pla2g2a Phospholipase A2, group IIA AMF[26,34] 14.4
Retnlb Resistin like beta AMF[25,27,40] 8.8
Pla2g4c Phospholipase A2, group IVC AA metabolism?[41] 8.6
Reg3g Regenerating islet-derived 3 gamma AMF[25,28] 7.6
Reg3b Regenerating islet-derived 3 beta AMF[25] 5.1
Gsdmc2 Gasdermin C2 Unknown[42] 4.1
… …… …
Casp14 Caspase 14 Proteinase?[43] 0.23
Cyp4b1 Cytochrome P450, family 4, subfamily b, polypeptide 1 Metabolism of carcinogens?[44] 0.16
AMF, antimicrobial factor. AA, arachidonic acid.
doi:10.1371/journal.pone.0017996.t001
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Antibiotic treatment started with three days of amphotericin-B
(Bristol Meyers Squibb, New York City, NY) 0.1 mg/ml,
administered by gavage 12h
21 (Figure 2A). From day three, water
flasks were supplemented with ampicillin (Bristol Meyers Squibb,
New York City, NY) 1 g/l and antibiotic concoction consisting of
vancomycin (Abbot, Abbot Park, IL) 5 mg/ml, neomycin
(Invitrogen, Carlsbad, CA) 10 mg/ml, metronidazol (Actavis,
Hafnarfjordur, Iceland) 10 mg/ml, and amphotericin-B (Bristol
Meyers Squibb) 0.1 mg/ml was administered by antibiotic gavage
12h
21. Gavage volume of 10 ml/kg body weight was delivered
with a stainless steel tube without prior sedation of the mice. Fresh
antibiotic concoction was mixed every day and ampicillin and
water was renewed every 7th day.
Bacterial cultivation of feces
Day 13 and day 24 of the antibiotic treatment mice were fixed
to defecate directly into a pre-weighted 2 ml capped microtube
(Sarstedt, Nu ¨mbrect, Germany) prefilled with 1 ml sterile ice-cold
phosphate-buffered saline (PBS). Tubes with fecal pellets were kept
on ice, weighed and the weight of the pellets calculated (median
46 mg, range 17–120). Fecal pellets were resuspended in the 1 ml
PBS by vortexing and by bashing with a sterile bacteriological
loop. The fecal suspension was then plated on blood agar,
anaerobic blood agar (hemin – vitamin K agar), and yeast agar
(Sabouraud agar) in doubles with 100 ml suspension on each plate.
Blood agar and Sabouraud agar plates were incubated aerobically
at 37uC with 5% CO2 for 72 hours, while anaerobic blood agar
plates were incubated at 37uC in anaerobic conditions for
Figure 5. Antibiotic gavage treatment alters gene expression profile of the colonic epithelium. Gene expression profile of colonic
epithelial cells isolated from mice subjected to 17 days of treatment with vancomycin, neomycin, metronidazol, and amphotericin-B every 12 hours
by gavage with ampicillin ad libitum in drinking water (Treated) compared to mice gavaged with water only (Untreated). All Treated mice exhibited
successful depletion of cultivable intestinal microbiota (,1 cfu/mg feces). (A) Heat-map analysis of significantly (p,0.05) differentially expressed
genes with .two-fold change organized in dendrogram according to Eukledian relation of the differentially expressed genes. Colors indicate
absolute expression of one gene estimated by mean values of the multiple probes detecting each gene on the chip. Each row represent one gene,
each column represent one mouse. (B) Gene ontology map folder enrichment analysis of differentially expressed genes in MetaCore (GeneGo, St
Joseph, MI).
doi:10.1371/journal.pone.0017996.g005
Figure 6. Quantitative PCR validates colonic IEC gene expression profiles of antibiotic treatment in relation to germ-free mice.
Quantitative reverse transcriptase PCR of colonic intestinal epithelial cells (IEC) isolated from mice subjected to 17 days of treatment with vancomycin
(V), neomycin (N), metronidazol (M), and amphotericin-B (Amf-B) every 12 hours by gavage with ampicillin (A) ad libitum in drinking water (VNMAmf-
B+A) compared to mice gavaged with water only (Sham) and from colonic IEC of untreated germ-free mice (GF) and their conventional controls
(Conv). Target gene listed on top of each panel and plotted in relation to the house-keeping gene Hprt. Each symbol represents one mouse,
horizontal bars represent medians. Mann-Whitney analyses between VNMAmf-B+A and Sham, p,0.05 for all genes.
doi:10.1371/journal.pone.0017996.g006
Depleted Intestinal Microbiota in Mice
PLoS ONE | www.plosone.org 10 March 2011 | Volume 6 | Issue 3 | e1799696 hours. At the end of incubation the numbers of colonies on the
plates were counted and the number of bacteria per mg of feces
calculated. Evaluation of cultivated agar plates was performed by
an experienced bacteriologist (P.G.) The detection limit of the
assay was defined as 1 cfu/mg feces. Only mice successfully
depleted (,1 cfu/mg feces) were included in phenotypic and gene
expression analyses.
As a positive control for the depletion verification assay, and to
enumerate cultivable microbes with the fecal collection procedure,
fecal pellets from untreated mice were collected with the above
described procedure. Serial dilutions made in sterile PBS and suitable
dilutions were plated on selective media for intestinal Gram negative
rods, enterococci, anaerobic Gram negative rods (Bacteroides spp),
Clostridium spp, Lactobacillus spp and Bifidobacterium spp. The aerobic
agar plates were incubated in 37uCw i t h5 %C O 2 for 48 hours while
anaerobic agar plates were incubated in 37uC for 48 hours. After
incubation the numbers of colonies on the plates were counted and
the number of bacteria per mg of feces was calculated.
16S rRNA gene quantification
In the same procedure as fecal pellets were collected for
cultivation, the mice were let to defecate directly into a dry 1.5 ml
capped microtube (Sarstedt, Nu ¨mbrect, Germany) which was snap
frozen in liquid nitrogen and stored at 270uC until use.
DNA was isolated from bacterial fecal pellets with QIAamp
DNA Stool Mini Kit (Qiagen, Hilden, Germany) and quantified
by spectrophotometry at 260 nm. Degenerate primers for V2 and
V6 region of bacterial 16S genes were as previously de-
scribed[37,38] and primers for mouse genomic DNA was designed
with Primer3 (frodo.wi.mit.edu) (Table 2). All PCR reactions were
carried out with 50 ng of DNA, EvaGreenH (Biotium, Hayward,
California) and Taq2000 in a Stratagene MX3000P with a 15 min
activation step (95uC); then 40 cycles of 30 s denaturation (95uC),
30 s annealing (60uC for 16S-V2 and mpIgR-genomic, 55uC for
16S-V6), and 30 s extension (72uC). The efficiency of each PCR
was determined by dilution series of template. The number of 16S
DNA copies was related to the number of mouse genomic DNA
copies for each sample. Samples with a threshold crossing point
.32 cycles for the genomic PCR were deemed poorly amplifiable
and excluded from analysis.
Organ evaluation
After 17 days of antibiotic treatment mice were anaesthetized with
150 mlH y p n o r m H (fentanyl citrate 0.315 mg/ml and fluanison
Table 2. PCR primers used for amplification of bacterial 16S, mouse genomic DNA, and colonic IEC target genes.
Target Primer name Sequence
16S V2 region 16S-V2-101F[
37] AGYGGCGIACGGGTGAGTAA
16S-V2-361R CYIACTGCTGCCTCCCGTAG
16S V6 region 16S-V6-784F[
38] AGGATTAGATACCCTGGTA
16S-V6-1061R CRRCACGAGCTGACGAC
Mouse pIgR genomic region mpIgRgenomic.for TTTGCTCCTGGGCCTCCAAGTT
mpIgRgenomic.rev AGCCCGTGACTGCCACAAATCA
Angiogenin, ribonuclease A family, member 4 Ang4.for TCTCCAGGAGCACACAGCTA
Ang4.rev AAGGACATGGGCTCATTGTC
Phospholipase A2, group IIA Pla2g2a.for CTGTTGCTACAAGAGCCTGG
Pla2g2a.rev TTTTCTTGTTCCGGGCGAAA
Resistin like beta Retnlb.for AGGATCAAGGAAGCTCTCAGTC
Retnlb.rev ATTTCCATTCCGGATATCCCA
Phospholipase A2, group IVC Pla2g4c.for AAGGCTCTCAGACTGTGGAG
Pla2g4c.rev GCCCACAGTACCCTGAAAAC
Regenerating islet-derived 3 gamma Reg3g.for ACATCAACTGGGAGACGAATC
Reg3g.rev TTTGGGATCTTGCTTGTGGCTA
Regenerating islet-derived 3 beta Reg3b.for CCTTAGACCGTGCTTTCTGTG
Reg3b.rev GTCCATGATGCTCTTCAAGACA
Gasdermin C2 Gsdmc2.for GGACCTGGAGGCTAACTTGA
Gsdmc2.rev CCTTTCCATCCGGCAAAACT
Caspase 14 Casp14.for ATCTCAGGAGAAGCTTGGGG
Casp14.rev TCTGGCTTTCAGCACCTTTG
Cytochrome P450, family 4, subfamily b, polypeptide 1 Cyp4b1.for TGATCCTGATGGTAACCGTCC
Cyp4b1.rev CATAGGGGAACTGTTCGGTC
Hypoxanthine guanine phosphoribosyl transferase HPRT.for TGATCAGTCAACGGGGGACA
HPRT.rev TTCGAGAGGTCCTTTTCACCA
Beta 2 microglobulin B2m.for TGACCGGCCTGTATGCTATC
B2m.rev GCAGTTCAGTATGTTCGGCT
Target region, name and sequence of primers used in this study. The matching forward and reverse primers targeted to mouse cDNA lie in separate exons of each gene.
doi:10.1371/journal.pone.0017996.t002
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B. Braun Melsungen AG, Melsungen, Germany) subcutaneously and
sacrificed by cardiac puncture. Abdominal organs were swiftly
dissected and evaluated by a technician blinded to the treatment of
the individual animal. Macroscopically visible Peyer’s patches along
the entire length of the small intestines from the ventricle to the
ileocecal junction were counted. Cecum was gently put on its side
along a ruler, digitally photographed and with the software
analySISpro (Olympus Europa, Hamburg, Germany) the longitudi-
nal cross section area of the cecum was calculated. The intact spleen
was excised, abdominal fat gently removed, and the spleen was put in
10% formalin for 24 h, and then removed from the formalin, excess
liquid wiped off with a filter paper, and the spleen was weighted.
Immunohistochemistry
Colons of sacrificed mice were swiftly dissected and flushed with
2610 ml of ice cold PBS. A 1.5 cm piece of the middle colon was
cut off and instantly fixed in 10% formalin for 24 h at 4uC before
being automatically processed (TP 1050, Leica Microsystems,
Wetzlar, Germany) and embedded in paraffin. Sections were cut
at 4 mm thickness, deparaffinized and incubated 20 minutes in
preheated 0.05% citraconic anhydride pH 7.4 at 98uC. After
cooling to room temperature the sections were incubated 18 h
with rabbit anti-Ki67 (Abcam, Cambridge, UK) or isotype control
(rabbit anti-hemocyanin, Sigma, St. Louis, MR) at 4uC. After
washing with PBS (pH 7.4) sections were incubated 90 minutes
with Alexa Fluor 488 conjugated goat anti-rabbit IgG (Molecular
Probes, Eugene, OR) at room temperature. After another washing
in PBS sections were stained with Hoechst dye before being rinsed
in water and mounted with PVA under cover slips.
Slides were evaluated by one examiner (D.H.R) a blinded
fashion with the help of microscope (Eclipse E800, Nikon, Tokyo,
Japan) fitted with a digital camera and imaging software
(AnalySISpro 3.2, Olympus Soft Imaging System GmbH,
Mu ¨nster, Germany). Enumeration of Ki67
+ cells were performed
by calculating the mean number of positive cells in 5–8 crypts in
each transverse section ensuring crypts were cut to display the full
crypt heights.
Isolation of colonic IECs and microarray
After 17 days of antibiotic treatment mice were anaesthetized
with 150 ml HypnormH (fentanyl citrate 0.315 mg/ml and
fluanison 10 mg/ml, VetaPharma Ltd) and midazolam (5 mg/
ml, B. Braun Meslungen AG) subcutaneously and bled to death by
cardiac puncture. Colon was swiftly excised and flushed with 26
10 ml ice cold PBS (w/o Mg
2+ and Ca
2+) and kept moist.
Mesenteric and adipose tissue was removed from the colon which
was subsequently opened longitudinally, then cut transversally in
5 cm long pieces and incubated 25 min in 25 ml 20 mM EDTA
(Sigma-Aldrich, St. Louis, MO) at room temperature on a shaker
before being vigorously hand shaken for 5 minutes. The colonic
IECs were harvested in a fresh tube, washed twice in ice cold PBS,
resuspended in TRI ReagentH (Ambion Applied Biosystems,
Foster City, CA), and stored at 270uC until RNA isolation
according to manufacturer’s instructions.
Gene expression profiling was performed at the Microarray
Core Facility at The Norwegian Radium Hospital (Oslo, Norway).
Total RNA corresponding to samples of 5 microbiota depleted
mice and 6 control mice were labeled and hybridized to Illumina’s
MouseWG-6 v2.0 Expression BeadChips (Illumina, Inc., San
Diego, CA) according to manufacturer’s protocol. Normalization
and statistical analysis of gene expression was performed in R
(www.r-project.org) using Bioconductor packages and differentially
expressed genes were identified using moderated t-statistics with
an adjusted p-value ,0.05. Differentially expressed genes were
further analyzed in MetaCore (GeneGo, St Joseph, MI) to identify
functional enrichment. Process and pathways were selected based
on a p-value , 0.05. The complete gene expression dataset can be
viewed in the Gene Expression Omnibus (GEO) repository
accession number GSE22648 (www.ncbi.nlm.nih.gov/geo/que-
ry/acc.cgi?acc=GSE22648). Data submitted complied with
MIAME standards.
Quantitative RT-PCR
Epithelial cells and mRNA were isolated as described above.
cDNA was synthesized with Superscript
TM III Reverse transcrip-
tase (Invitrogen) and 20 pmol/ml oligo(dT) according to manu-
facturer’s protocol. The PCR primers were selected with the ‘‘Pick
PCR primer’’ tool available from NCBI (http://www.ncbi.nlm.
nih.gov) making sure each primer pair was separated by an intron
on genomic DNA. The optimal Mg
++ concentration was
determined empirically for each primer pair and PCR performed
with EvaGreenH (Biotium, Hayward, California) and Taq2000 in
a Stratagene MX3000P with a 15 min activation step (95uC); then
35 cycles of 30 s denaturation (95uC), 30 s annealing (60u), and
30 s extension (72uC). The median value of triplets were used to
calculate relative expression of each gene according to the DDCt
method[39]. Normalization to the housekeeping genes hprt or b2-
microglobulin gave similar results.
Statistics
Where appropriate, statistical differences were calculated by
Mann-Whitney two- tailed test using the software Prism5
(GraphPad Softvare Inc., La Jolla, CA).
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